Article Contents
- Introduction
- An overview of important Journal Metrics
- A list of the top ranked journals for this therapeutic area
- Ways to stay up to date with the latest research developments
Introduction
Need to get your hands on the latest research and perspectives on Pneumonia but not sure where to look? Well, we have done the legwork for you.
Viruses and bacteria such as Streptococcus pneumoniae, Haemophilus influenzae type B and respiratory syncytial virus (RSV) are common causes of pneumonia. Pneumonia is also a complication of SARS-CoV-2 (COVID-19).
Ongoing pneumonia research is crucial to help health professionals diagnose and treat patients. Research also helps improve our understanding of if, and how, COVID-19 affects the lungs differently than non-COVID-19 pneumonia.
To support this, we’ve collated a list of the top 10 respiratory journals that regularly publish pneumonia research findings, including up-to-date COVID-19 pneumonia research.
Here you will find the top 10 Pneumonia & Respiratory journals ranked by the 2-year Journal Impact Factor (2-JIF) – a measure of the frequency with which the articles within the journal are cited in a particular 2-year period.
We have also included these other factors for each journal in our assessment to round off the picture.
Journal Metrics
Impact factor*
The Journal Impact Factor (JIF) is based on Web of Science data and only includes documents such as articles and reviews. The JIF helps to understand the importance of how often articles are cited by addressing the bias that arises from comparing citation numbers. This bias tends to advantage bigger journals over smaller ones, those published more often over those with fewer issues, and older journals over newer ones. This is because larger or older journals usually have more articles to be cited. By considering the impact factor, we can more fairly compare journals by taking into account these differences in size, publication frequency, and age. A JIF of 3 or more is considered good and 1 is average.
CiteScore*
CiteScore is based on Scopus data for all indexed documents, including articles, letters and editorials, as well as articles and reviews. The CiteScore for a particular year is calculated by dividing the number of citations to all indexed documents within the journal from that year and the three preceding years by the total number of documents published in the journal within that same period.
*Impact factor and CiteScore have the most meaning when used to compare journals within the same therapeutic area. Many academics value a journal’s Impact Factor over its Citescore; therefore they will use the impact factor to rank other journals in the same field.
SCImago Journal Rank (SJR)
The SCImago Journal Rank (SJR) indicator evaluates the prestige of academic journals by considering not only the number of citations a journal receives but also the prestige of the journals that issue these citations. An SJR >1.0 is above average. This measurement can be helpful to rank journals within the same field and category.
Source Normalised Impact per Paper (SNIP)
Source Normalised Impact per Paper (SNIP) weights citations based on the total number of citations in a subject field to provide a contextual, subject-specific metric. A SNIP over 1.0 means a journal has more citations than average.
Other Journal considerations
In addition to SJR ranking and journal impact factor, a good quality journal generally has the following characteristics:
- It is indexed on PubMed, Google Scholar, Scopus, Web of Science or another reputable journal index.
- It has an up-to-date website, a clear scope, extensive information for authors and readers, and a publicly visible editorial board consisting of appropriately qualified board members affiliated with accredited universities and research institutions.
- Each article is assigned a Digital Object Identifier (DOI).
Top 10 Pneumonia & Respiratory journals Journals
Selecting the right journal for your research is a critical step that can make or break the impact of your work. This is where a medcomms agency like Rx Communications can become an essential ally. With a deep understanding of the scientific publishing world and high levels of therapeutic area expertise, a medcomms agency worth its salt should be able to provide support at any stage of the publishing process. This includes assisting in finding journals that match your research area and larger aims, and shaping your manuscript so it reflects the ethos and audience of your chosen journal, as well as guiding you through the entire submission process including managing revisions, and planning for post-publication promotion and dealing with rejection.
Rx can increase your chances of not just getting published, but also ensuring your research makes the waves it deserves.
The Lancet Respiratory Medicine
The Lancet Respiratory Medicine, a leading journal in respiratory medicine and critical care, publishes original research and insightful reviews across a broad spectrum of topics. These include but are not limited to, conditions like asthma, COPD, lung cancer, and pneumonia, as well as areas such as tobacco control, intensive care, and respiratory infections. The journal features various types of content, including articles, reviews, personal views, comments, and news, aiming to enlighten and influence clinical practice in respiratory medicine and critical care.
- Impact Factor: 76.2
- CiteScore: 74.8
- SJR: 11.204
- SNIP: 10.81
- H-Index: 159
European Respiratory Journal
The European Respiratory Journal is the flagship journal of the European Respiratory Society. It includes articles, reports, guidelines, editorials and other correspondence. Its wide range of content spans both pediatric and adult respiratory medicine. Recent pneumonia articles include the risk of community-acquired pneumonia in children using gastric acid suppressants, the use of aspirin to reduce cardiovascular effects in patients with pneumonia, and COVID-19 and pneumonia.
- Impact Factor: 29.4
- CiteScore: 25.3
- SJR: 4.722
- SNIP: 3.602
- H-Index: 267
American Journal of Respiratory and Critical Care Medicine
Published twice a month by the American Thoracic Society, the American Journal of Respiratory and Critical Care Medicine publishes content that helps health professionals and researchers improve their understanding of the pathophysiology and treatment of respiratory conditions, including pneumonia. Some of the content is open access.
- Impact Factor: 24.7
- CiteScore: 28.7
- SJR: 6.237
- SNIP: 4.582
- H-Index: 404
Journal of Thoracic Oncology
Journal of Thoracic Oncology is the official journal of the International Association for the Study of Lung Cancer, published monthly. It features peer-reviewed research on the prevention, detection, diagnosis, and treatment of thoracic malignancies. Supporting open access, the journal includes studies on lung cancer staging, the impact of pollution on lung cancer, and new treatments for ALK-positive non-small-cell lung cancer, catering to oncologists and respiratory specialists.
- Impact Factor: 20.4
- CiteScore: 31.9
- SJR: 5.866
- SNIP: 3.593
- H-Index: 161
Pulmonology
Pulmonology is the official publication of the Portuguese Society of Pulmonology. This open-access journal has an impact factor of 11.7 and publishes a mix of clinical and experimental research in respiratory medicine. Its content ranges from COVID-19 rehabilitation to the molecular characterization of lung cancer, serving as a crucial resource for pulmonologists and researchers in the field.
- Impact Factor: 11.7
- CiteScore: 13
- SJR: 1.641
- SNIP: 1.918
- H-Index: 32
Chest
Chest is published monthly and regularly includes pneumonia research, some of which is available as open access content. It is the official journal of the American College of Chest Physicians. You can also follow on Twitter.
- Impact Factor: 10.1
- CiteScore: 11.9
- SJR: 2.322
- SNIP: 2.002
- H-Index: 315
Thorax
Thorax is published monthly by BMJ Publishing Group and includes research that helps improve the understanding of respiratory conditions to support clinical practice. It is the official journal of the British Thoracic Society. You can also listen to Thorax podcasts and follow on Twitter and Facebook.
- Impact Factor: 10
- CiteScore: 14.3
- SJR: 3.133
- SNIP: 2.223
- H-Index: 242
European Respiratory Review
The European Respiratory Review is published by the European Respiratory Society and provides open access content focused on all areas of respiratory medicine, including pneumonia. Because new articles are published continuously online, the journal is a great resource to bookmark to stay informed about the latest respiratory research. You can also follow the European Respiratory Society on Facebook, LinkedIn and Twitter.
- Impact Factor: 7.5
- CiteScore: 12.8
- SJR: 2.695
- SNIP: 2.596
- H-Index: 88
American Journal of Respiratory Cell and Molecular Biology
The American Journal of Respiratory Cell and Molecular Biology is the companion journal of the American Journal of Respiratory and Critical Care Medicine. Recent articles include metabolic adaptation in methicillin-resistant Staphylococcus Aureus pneumonia, and immune modulation to improve survival of viral pneumonia in mice.
- Impact Factor: 6.4
- CiteScore: 11.7
- SJR: 1.805
- SNIP: 1.129
- H-Index: 172
American Journal of Physiology - Lung Cellular and Molecular Physiology
This journal is published by the American Physiological Society. As its name suggests, the content published focuses on the molecular, cellular and integrative aspects of cells and components of the respiratory system. Featuring complex articles such as how inhibition of the lipoxin A4 and resolvin D1 receptor impairs host response to acute lung injury caused by pneumococcal pneumonia in mice, this journal is most relevant for researchers rather than health professionals providing patient care.
- Impact Factor: 4.9
- CiteScore: 9.5
- SJR: 1.466
- SNIP: 0.96
- H-Index: 175
Publish or Perish - as true now as it ever was
In the high-stakes world of pharma and biotech, "Publish or Perish" isn't just a catchy phrase—it's the stark reality. For pharma companies and researchers, it's not enough to develop breakthroughs; the real challenge lies in getting those findings recognised in top journals. In this game, it's not just about playing your cards right; it's about having a seasoned player on your team. With Rx Communications in your corner, you’ll be giving yourself the best chance to make an impact with your research. Explore our Publications Support Services here.
How to Stay Up-to-Date with Pneumonia Research Developments
For pharma professionals and researchers working in the field of pneumonia, it is vital to stay abreast of the latest research advancements. To stay on top you might:
- Consider subscribing to our newsletter and receive updates to our top journal lists as well as other relevant industry and therapeutic developments as they happen.
- Register for an account with your selected journal to get direct access to new research as it's published.
- Customise an RSS feed for your selected journals to also further streamline the process, delivering the latest papers and articles directly to your digital doorstep.
- Setting up a Google alert with pneumonia research keywords to capture relevant news and studies from across the web.
- Lastly, don't underestimate the power of social media; by following the publishers and journals in the field, you'll tap into a community of shared knowledge and discourse.
* Article originally written by Sarah Cahill and published in 2021, updated by Beth Howe and the Rx Team for 2024!
